ACTINIC KERATOSIS - SCORE
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - South Carolina policy alerts
Know when Blue Cross Blue Shield - South Carolina releases new policies or updates existing guidance.
Monitor payer policy activity
This South Carolina PDP step-therapy policy governs coverage of diclofenac sodium gel 3% for actinic keratosis. New starts require a trial of either topical fluorouracil or topical imiquimod.
No material clinical or coverage changes in this revision.
Coverage Criteria
Actinic Keratosis Initial Therapy
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.